Literature DB >> 11079742

Increased O-GlcNAc transferase in pancreas of rats with streptozotocin-induced diabetes.

Y Akimoto1, L K Kreppel, H Hirano, G W Hart.   

Abstract

AIMS/HYPOTHESIS: Streptozotocin (STZ), a chemically reactive analogue of N-acetylglucosamine, induces necrosis of the beta cells, resulting in diabetes mellitus. Glucose-induced insulin resistance is mediated by increased activity of the hexosamine pathway. We aimed to examine the regulation of O-GlcNAc transferase expression and activity in the normal and streptozotocin diabetic pancreas.
METHODS: Rats were made diabetic by an injection of streptozotocin (65 mg/kg). The expression of O-GlcNAc transferase protein was examined by immunoblot analysis. Activity of O-GlcNAc transferase was assayed by the incorporation of [3H]GlcNAc into the synthetic peptide. Localization of O-GlcNAc transferase was done by immunohistochemistry. The change of O-GlcNAc modification of proteins was examined by immunoblot analysis.
RESULTS: In the STZ-induced diabetic pancreas, a severe loss of beta cells was observed, whereas alpha cells had increased in number. The diabetic pancreas showed an increase in the expression of O-GlcNAc transferase at the protein level and the O-GlcNAc transferase activity in it was increased significantly (p < 0.05). An increase in the immunostaining intensity in the cytoplasm of islet beta cells was also observed in the diabetic pancreas, whereas exocrine cells and islet cells other than beta cells showed little change in immunostaining intensity. The pancreas of STZ-diabetic rats showed a 3.1-fold increase in total cellular O-GlcNAc-modified proteins. CONCLUSION/
INTERPRETATION: These findings indicate that O-GlcNAc transferase plays an important part in the modulation of O-GlcNAc concentrations in the pancreas and suggest that the increase in O-GlcNAc modification of the proteins correlates closely with diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079742     DOI: 10.1007/s001250051519

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

Review 1.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

Review 2.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

3.  Metabolic Stress and Cardiovascular Disease in Diabetes Mellitus: The Role of Protein O-GlcNAc Modification.

Authors:  Yabing Chen; Xinyang Zhao; Hui Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

4.  High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.

Authors:  Sujith Dassanayaka; Ryan D Readnower; Joshua K Salabei; Bethany W Long; Allison L Aird; Yu-Ting Zheng; Senthilkumar Muthusamy; Heberty T Facundo; Bradford G Hill; Steven P Jones
Journal:  Biochem J       Date:  2015-04-01       Impact factor: 3.857

Review 5.  Introduction of hyperglycemia and dyslipidemia in the pathogenesis of diabetic vascular complications.

Authors:  Yizhen Xu; Zhiheng He; George L King
Journal:  Curr Diab Rep       Date:  2005-04       Impact factor: 4.810

6.  Glucose induces MafA expression in pancreatic beta cell lines via the hexosamine biosynthetic pathway.

Authors:  Nathan L Vanderford; Sreenath S Andrali; Sabire Ozcan
Journal:  J Biol Chem       Date:  2006-12-01       Impact factor: 5.157

7.  Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.

Authors:  Michele E Forsythe; Dona C Love; Brooke D Lazarus; Eun Ju Kim; William A Prinz; Gilbert Ashwell; Michael W Krause; John A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-01       Impact factor: 11.205

Review 8.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

9.  Two-dimensional gel-based approaches for the assessment of N-Linked and O-GlcNAc glycosylation in human and simian immunodeficiency viruses.

Authors:  David R M Graham; Megan J Mitsak; Steven T Elliott; Dawn Chen; Stephen A Whelan; Gerald W Hart; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2008-12       Impact factor: 3.984

10.  O-GlcNAcase deficiency suppresses skeletal myogenesis and insulin sensitivity in mice through the modulation of mitochondrial homeostasis.

Authors:  Xun Wang; Zhihui Feng; Xueqiang Wang; Liang Yang; Shujun Han; Ke Cao; Jie Xu; Lin Zhao; Yong Zhang; Jiankang Liu
Journal:  Diabetologia       Date:  2016-03-18       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.